FDA Advisers Back Pfizer’s COVID-19 Vaccine For Young Kids

This October 2021 photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. Kid-size doses of Pfizer’s COVID-19 vaccine may be getting closer as government advisers on Tuesday, Oct. 25, 2021 began deliberating whether there’s enough evidence that the shots are safe and effective for 5- to 11-year-olds. (Pfizer via AP)

(AP) — U.S. health advisers have endorsed kid-size doses of Pfizer’s COVID-19 vaccine for younger children.

The vote Tuesday by the Food and Drug Administration panel moves the U.S. closer to vaccinating children ages 5 to 11. The FDA isn’t bound by the panel’s recommendation and is expected to make its own decision within days. If regulators agree, shots could begin as early as late next week. Young kids would get a third of the dose given to teens and adults.

A study found kid-size vaccinations are nearly 91% effective at preventing infections that cause symptoms. Moderna also is studying its vaccine for young children.


Texas Executions Delayed Over Religious Rights Claims

Previous article

US Asks UK Court To Permit Extradition Of WikiLeaks’ Assange

Next article

You may also like